Dexmedetomidine Versus Morphine During Cooling Therapy in Neonates

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

July 1, 2025

Primary Completion Date

September 30, 2027

Study Completion Date

June 30, 2028

Conditions
Hypoxic Ischemic Brain InjuryNeonatal EncephalopathyPerinatal Anoxic-ischemic Brain Injury
Interventions
DRUG

Dexmedetomidine Infusion

Dexmedetomidine infusion given for sedation during therapeutic hypothermia. Dexmedetomidine infusion at a starting dose of 0.2 μg/kg/h, with titration in 0.1 μg/kg/h increments with a maximum of 0.5 μg/kg/h based on objective assessment of sedation.

DRUG

Morphine Infusion

Morphine infusion given for sedation during therapeutic hypothermia. Morphine infusion at a starting dose of 4 μg/kg/h, with titration in 2 μg/kg/h increments with a maximum of 10 μg/kg/h based on objective assessment of sedation.

Trial Locations (1)

L8N3Z5

McMaster Children's Hospital, Hamilton

All Listed Sponsors
lead

Ipsita Goswami

OTHER